medigraphic.com
ISSN 1405-8871 (Print)

2011, Number 2

<< Back Next >>

Aten Fam 2011; 18 (2)

Relation between Uterine Cervical Dysplasia and the Human Papillomavirus in a Primary Care Unit in Michoacan, Mexico

López GJA, Villa BR, Martínez MF, Mejía RO, Ochoa BN

Language: Spanish
References: 11
Page: 38-40
PDF size: 172.14 Kb.


ABSTRACT

Objective: to determine the relation of the Human Papillomavirus Infection (HPVI) with dysplasias and to describe the reference process. Material and methods: cross sectional and descriptive study. Clinical records of a non random sampling were reviewed with a positive result of HPVI and dysplasia in the period of January 1 to December 31, 2008, and the results of endocervical cytology, post colposcopy and the histopathological result. The variables studied were the cytology report, colposcopy and biopsy. The data are presented as media ± DE, percentages and frequencies. Results: 10,668 cytology were performed in the DOC CACU program, of which 82 were HPVI positive and/or dysplasia, 70 attended for colposcopy, 58 were confirmed by biopsy. Diagnosis of cervical vaginitis in 22 patients (37.9%) high grade injury (LIE-AG) in 20 (34.4%) low-grade injury (LIE-AG) in 14 (24.1%) and invasive carcinoma in 2 (3.4%). The association was presented in 19 patients (32.7%). Conclusions: the relation of HPVI with dysplasias is high. The program coverage is broad, however in the process of confirming the diagnosis through biopsy, a high percentage of patients can be lost.


REFERENCES

  1. Walboomers JMM, Jacobs MV, Manos MM, Bosh FX, Kummer JA, Shah KV, et.al. Human papillomavirus is a nessesary cause of invasive cervical cancer. Worldwide. J. Pathol. 1999; 189:12-19.

  2. Rivera RL, Rangel SJI, Hernández GC, Velasco MHE, Pérez RM. Frecuencia de displasias y cáncer cervical en mujeres del Estado de Querétaro, México. Rev Oncología. 2003; 5(8): 471-75.

  3. Dunne EF, Unger ER, Stemberg M, et al. Prevalence of HPV Infection among Females in the United States. JAMA. 2007. 29 (8): 813-19.

  4. Herrero R, Castle PE, Shiffman M, Bratti MC, Hideshein A, Morales J, et al. Epidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica. JID. 2005.191(1): 1796-1807.

  5. Campos AM, Figueroa NB, González GG. Prevalencia de infección cervical por virus del papiloma humano en mujeres derechohabientes de la UMF No 80. [Tesis de posgrado] Universidad Michoacana de San Nicolás de Hidalgo. Instituto Mexicano del Seguro Social. 2007.

  6. Sotelo RR, Flores HL, Ibarra DRM, Solorza LG, Osorio M, García CA. Estudio comparativo preliminar entre citología cérvico uterina convencional y en monocapa. Gamo 2005; 4 (1): 11-14.

  7. Richard K, Dziura B, Hornish A. Cell block preparation as a diagnostic technique complementary to fluid-based monolayer cervicovaginal specimens. Acta Cytol 1999. 43 (1): 49-73.

  8. Coronel BP, Coronel PP. Estudio exploratorio de las lesiones pre malignas en el reporte citológico del cuello uterino. Rev Med Univ. Ver. 2003; 3 (1): 23-30.

  9. Brown D.R, Shew M.L, Qadadri B, Neptune N, Vargas M, Tu W, et al. A longitudinal study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women. JID. 2005. 191(15): 182-92.

  10. Sam Soto S, Gayón Vera E. Guía práctica para el abordaje y manejo de lesiones ano genitales por virus de papiloma humano en adolescentes. Act Pediatric. Mex. 2006. 27(3): 151-156.

  11. Sijvarger CC, González JV, Prieto A, Messmer AG, Mallimaci MC. Epidemiología de la infección cervical por virus Papiloma Humano en Ushuaia, Argentina. Revista Argentina de Microbiología. 2006;38: 19-24.




2020     |     www.medigraphic.com